Speakers

Speakers at the Tech Transfer Summit Europe 2010

 

Alain Beretz, President, University of Strasbourg, France

Alexey Konov, CEO, Bioprocess Investment, Russia

Allan Liu, VP (Wanbang BioPharma) Fosun Pharmaceuticals, China (t.b.c.)

Anne Lane, Director Biopharm, University College London, U.K.

Anne Mette Wolff, Senior IP Manager, Novozymes, Denmark

Beat Mollet, Director Intellectual Property,Nestlé Research Centre, Switzerland (t.b.c.)

Bernhard Mohr, Investment Manager, BASF Venture Capital, Germany

Binah Baum, Manager, TMI Technology Maturation & Incubation, & Special Advisor to MATIMOP –
National Innovation Support Agency, Israel

Bonnie Harbinger, Deputy Director, Office of Technology Transfer, NIH, USA

Caroline Rigot, Conectus General Manager, Head of Strasbourg University Technology Transfer Office, France

Cécile Tharaud, Executive Director, Inserm Transfert, France

Claes Post, Business Development, Linkoping University Innovation,

David Chilvers, CEO, NHS Innovations, U.K.  (t.b.c.)

Elena Lurie Luke, Global Director Bioscience Business Development, Procter & Gamble, U.K.

Emmanuel Chantelot, Executive Director, EBE European Biopharmaceutical Enterprises

François Bocquel, President, Alsace BioValley President, & CEO Phenopro, France

Frank Heemskerk, CEO, RiMS, Belgium

Gary Howes, Partner, Fasken Martineau, UK

Gerold Breit, Executive Director, Technology Transfer Office, University of Manitoba, Canada

Glen Steinbach, CFO, Technology Transfer Office, Johns Hopkins, USA

Graziano Seghezzi, Partner, Sofinnova Partners, France

Gunnar Casserstedt, CFO, Karolinska Development, Sweden (t.b.c.)

Helmut Schuhsler, Managing Partner, TVM Capital, Germany

Iain Gillespie, Head, Biotechnology Division, OECD (t.b.c.)

Jacques Darcy, Head of Product Development & Incubation, European Investment Fund

Jan C. Maier, CEO, Avedas AG, Germany

Jesse Schulman, Director, Research, Ferghana Partners, U.K.

Jørgen Thorball, XOVenture, Chairman, Pergamum, Sweden

Kari Paukkeri, CEO, Licentia Oy, Finland

Kevin Cullen, VP Surveys & Metrics, University of Glasgow, Vice President of ASTP, U.K.

Kevin Noonan, Partner, McDonnell Boehnen Hulbert & Berghoff, Editor, Patent Docs,  USA

Lila Feisee, Vice President, Global Intellectual Property Policy, BIO, USA

Lorne Meikle, President & Chairman, Life Sciences Ontario, Canada

Manfred Horst, Business Development, Merck & Co., France

Marcel Lubben, Managing Director, DSM Licensing, Netherlands

Marcus Kostka, Collaborative Research, Boehringer-Ingelheim, Germany

Margaret Beer, Senior Director & Head Licensing External Research, Merck & Co., U.K.

Mark McBride, Managing Director, Innovaro  (Pharmalicensing) U.K.

Markus Goebel, Managing Director, Novartis Venture Fund, Switzerland

Michiel de Haan, Managing Partner, Aescap Venture Management, Netherlands

Morton Juhl-Corydon, Director Licensing, Novozymes, Denmark

Nick Dunster, Senior Analyst, Wellcome Trust , U.K.

Nick Rodgers, CEO, IPSO Ventures, U.K.

Nicolas Carboni, Director, Alsace BioValley France

Olivier Drap, Manager Strategic Alliances, Worldwide Business Development, Pfizer, U.K.

Patrick Tricoli, Scouting & Partnering Int’l, Sanofi-Aventis, France

Paul Tully, Partner, MBHB, Chicago, USA

Peter Luke, Executive Director, Strategic Alliances, Pfizer, U.K.

Peter Ruile, COO, Ascenion GmbH, Germany

Rudy Dekeyser, Managing Director, VIB Technology Transfer, Belgium (t.b.c.)

Rupert Osborn, CEO, IP Pragmatics, U.K.

Ruxandra Draghia Akli, Director, Directorate Health, DG Research, European Commission

Samuel Ogunsalu, Principal Executive Commercial Development, Queen Mary Innovations, U.K.

Silvio Bonaccio, Head of Unit, Spin-Offs, ETH Transfer, Switzerland

Stéphane Huet, Director External Scientific Affairs, GSK Research Centre, France (t.b.c.)

Steve Meller, Global Innovation Catalyst, Procter & Gamble, USA (t.b.c.)

Tom Saylor, CEO, Arecor, & Chairman - EuropaBio SME Platform, U.K.

Tony Hickson, Director of Technology Transfer, Imperial Innovations, U.K.

Tony Sedgwick, CEO, Novacta Biosciences, U.K.

Werner Wolf, BioInnovations, Switzerland

Wilma Lukas, Senior S&E Officer, In-Licensing, Debiopharm S.A., Switzerland

Organized by

• 
• 
• 
• 
• 
• 
• 
•